Swiss drug giant looks for ways to lower U.S. prices amid tariff threat and admits Americans ‘pay for a large part of the innovations’
PositiveFinancial Markets

A Swiss drug giant is actively seeking ways to reduce the prices of medicines for Americans, acknowledging that U.S. consumers contribute significantly to pharmaceutical innovations. This initiative comes in response to potential tariff threats and reflects a commitment to finding constructive solutions that could alleviate the financial burden on patients. By collaborating with the government, the company aims to ensure that essential medications become more affordable, which is crucial for public health and access to necessary treatments.
— Curated by the World Pulse Now AI Editorial System